nRNP (U1-RNP and snRNP) antibodies


nRNP-antibodies are included in the analysis ENA screen. See ENA screen for indication, method, answer and reference range.


Occur in almost all patients with MCTD, in 5-50% of patients with SLE and is most common in patients with lung manifestations or signs of myositis, Raynaud’s phenomenon and positive RF-IgM. Antibodies may also occur in RA and polymyositis/ dermatomyositis and scleroderma. A few healthy people, as well as people with malaria, bilharzia and leishmaniasis, may have antibodies against nRNP.

Read more about sampling

20 years experience